Consider a 58-year-old man we’ll call Daniel, whose story shows how Cialis and riociguat can collide. Two years ago, after months of breathlessness on the stairs, he was diagnosed with pulmonary arterial hypertension (PAH), a form of high blood pressure in the arteries of the lungs. His care now runs through three offices. A pulmonologist at a pulmonary hypertension center manages his lung pressures and recently started him on riociguat (Adempas). A cardiologist checks his heart every six months. And when Daniel finally brings up erectile dysfunction, he does it at a quick primary care visit, where the doctor on duty has his blood pressure readings but not the PH center’s latest notes. Daniel leaves with a prescription for Cialis.
Daniel’s story is made up, but the gap in it is real. Cialis and riociguat are a contraindicated pair, meaning their labels say they should not be used together, because the combination can drop blood pressure too far. The interaction is well known to PH specialists and pharmacists. The risk comes from split care, where no single person sees the whole medicine list. This article explains why the pairing is dangerous, how it can happen in two different ways, and the simple habits that help a care team catch it.
The short version
- Cialis and riociguat (Adempas) both raise the same blood vessel relaxing messenger, cGMP. Together they can cause dangerously low blood pressure.
- The labels for Cialis and riociguat each list the combination as a contraindication. The Adempas label also names sildenafil and vardenafil.
- Tadalafil is itself a PAH treatment under the names Adcirca, Alyq and Tadliq, so the clash can happen when an ED prescription is added or when a PAH regimen is changed.
- Switching between a PDE5 inhibitor and riociguat requires a planned gap set by your PH team.
- Keeping one current medicine list and using one pharmacy are the most reliable safeguards.
What riociguat does, and why tadalafil is also a lung medicine
Riociguat is sold in the US as Adempas. It belongs to a drug class called soluble guanylate cyclase (sGC) stimulators. The FDA label approves it for adults with two conditions:
- Pulmonary arterial hypertension (PAH, WHO Group 1), to improve exercise capacity and functional class and to delay clinical worsening.
- Chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4) that persists or returns after surgery, or that can’t be treated with surgery. CTEPH is high lung pressure caused by old blood clots that have scarred the lung arteries.
Riociguat relaxes and widens the narrowed lung blood vessels, which lowers the pressure the right side of the heart has to pump against. It also relaxes blood vessels elsewhere in the body, which is why the label warns that it lowers blood pressure in general.
Here is the detail that surprises many patients. Tadalafil, the active ingredient in Cialis, is also an approved PAH medicine. It is sold for that purpose under different names: Adcirca and Alyq tablets, and Tadliq oral suspension. Sildenafil works the same way and is sold as Revatio for PAH and Viagra for erectile dysfunction. So the “ED pill” and the “lung pill” can be the very same molecule in different packaging, prescribed by different doctors for different reasons.
That overlap creates two distinct risks. The first is combining Cialis and riociguat, or any tadalafil product with riociguat, which is the subject of this article. The second is doubling up on tadalafil itself, for example taking Cialis on top of Adcirca, because two prescribers didn’t know about each other. Both are medicine-list problems as much as drug problems.
Pregnancy and riociguat: what changed in 2026
Riociguat carries a boxed warning for embryo-fetal toxicity. Based on animal data it may cause harm to an unborn baby, and it is contraindicated in pregnancy. The label says pregnancy should be ruled out before treatment begins, and that people who can become pregnant should use effective contraception before starting, during treatment, and for one month after the last dose. Anyone who thinks they may be pregnant should contact their prescriber right away.
For years, riociguat could only be prescribed and dispensed through a restricted safety program (a REMS) with certification and pregnancy-related requirements. In August 2026 the FDA approved a change stating that a REMS is no longer required for riociguat, concluding that the labeling is sufficient to convey the pregnancy risk. The boxed warning and the contraception advice remain. Your PH team will explain what pregnancy testing they recommend for you. This topic is less likely to affect a man being prescribed Cialis, but it matters for any household where a partner also takes riociguat, and for women with PAH reading about the drug class.
Two ways Cialis and riociguat can end up together
A drug interaction warning only helps if someone notices it at the right moment. With Cialis and riociguat, there are two common moments when it can slip past.
Pathway 1: an ED prescription added to riociguat
This is Daniel’s situation. Erectile dysfunction is a personal topic, and many men raise it with whichever doctor feels easiest to talk to, which is often not the lung specialist. The prescriber may be a primary care doctor, a urologist, an urgent care clinician or an online prescribing service. Cialis and riociguat come from different specialties, so if riociguat isn’t on that prescriber’s list, or if it appears under its brand name and nobody recognizes it, the conflict can be missed. A pharmacy computer would normally flag the pair, but only if both prescriptions are filled at the same pharmacy or the pharmacist has a complete list. Pills bought from unregulated websites skip every one of those checks.
Pathway 2: a change in the PAH regimen
The second pathway starts inside PH care. Many people with PAH begin treatment on a PDE5 inhibitor such as tadalafil (as Adcirca or Alyq) or sildenafil (as Revatio). Later, the PH team may decide to switch to riociguat, or switch from riociguat back to a PDE5 inhibitor. During a switch, the old and new medicine can overlap if the stop date and start date aren’t clearly communicated. A leftover bottle in the kitchen cabinet, an automatic mail-order refill that keeps arriving, or a misunderstanding about “finish what you have” can all lead to Cialis and riociguat, or another PDE5 inhibitor and riociguat, being taken in the same week.
Both pathways have the same fix: everyone on the care team, including the patient and the pharmacist, working from the same up-to-date list.
Why Cialis and riociguat lower blood pressure too far
Inside the muscle of every blood vessel wall there is a chemical messenger called cGMP. When cGMP levels rise, the muscle relaxes, the vessel widens and blood pressure falls. The body controls cGMP from two ends.
- The production end. An enzyme called soluble guanylate cyclase (sGC) makes cGMP. It is normally switched on by nitric oxide, a gas the body releases in blood vessel linings.
- The breakdown end. An enzyme called PDE5 breaks cGMP down, which ends the relaxation signal.
Riociguat works on the production end. It makes sGC more responsive to the body’s own nitric oxide and can also switch sGC on directly, even when nitric oxide is low. More cGMP gets made.
Tadalafil works on the breakdown end. It blocks PDE5, so cGMP isn’t cleared as quickly. More cGMP lingers.
One drug turns up the faucet and the other plugs the drain. Each is effective on its own, which is why both are useful PAH medicines. When Cialis and riociguat are combined, the cGMP signal can run far past what the body is used to, and blood vessels across the body open widely at once. The result can be symptomatic hypotension, meaning blood pressure low enough to cause dizziness, fainting or worse. The Adempas label lists co-administration with specific PDE5 inhibitors, including sildenafil, tadalafil and vardenafil, as a contraindication because of hypotension. The Cialis label says not to use it in people taking a guanylate cyclase stimulator such as riociguat.
People with pulmonary hypertension may be especially sensitive to a sudden drop in blood pressure, because the heart is already working hard to push blood through the lungs. That’s another reason PH specialists treat Cialis and riociguat as a pairing to avoid entirely.
Other medicines in the same web
The same cGMP logic explains several neighbouring warnings:
- Sildenafil (Revatio, Viagra) and vardenafil are PDE5 inhibitors and are contraindicated with riociguat, just like tadalafil.
- Nitrates and nitric oxide donors, such as nitroglycerin, isosorbide and amyl nitrite “poppers,” are contraindicated with riociguat in any form. They are also contraindicated with Cialis. Our article on Cialis and nitrates explains how to recognize them.
- Nonspecific PDE inhibitors such as dipyridamole and theophylline are listed as contraindicated with Adempas as well.
- Vericiguat (Verquvo) is another sGC stimulator, approved for certain adults with chronic heart failure. Its label says it should not be combined with other sGC stimulators such as riociguat, and that use with PDE5 inhibitors is not recommended because of the potential for hypotension. A heart failure patient on Verquvo who is offered Cialis should raise this with the cardiologist.
Common questions about Cialis and riociguat
Can I take Cialis if I’m on Adempas?
No. The Adempas label lists tadalafil and other PDE5 inhibitors as contraindicated, and the Cialis label says not to use it in people taking riociguat. If erectile dysfunction is a concern, tell your PH specialist. They can talk with you about which options fit with your lung treatment.
Is the risk lower if I take Cialis only once in a while?
No. Cialis and riociguat interact whether the tadalafil is daily or occasional, because a single dose stays in the body for a long time; its half-life is about 17.5 hours in healthy people. Occasional use still overlaps with riociguat, which is usually taken several times a day. The contraindication applies to any use, not just daily use.
My PAH doctor prescribes tadalafil. Can I use it for erections too?
That is a question for the PH specialist who prescribes it, and the answer depends on your treatment plan. What you should never do is add a separate Cialis prescription on top of Adcirca or Alyq, since they contain the same active ingredient. And if you’re on riociguat, you should not be taking any tadalafil product.
What about sildenafil (Viagra) instead of Cialis?
Sildenafil belongs to the same drug class and is also contraindicated with riociguat. Switching from one ED pill to another doesn’t remove the interaction.
I took Cialis and riociguat together. What should I do?
Call 911 if you feel faint, dizzy when standing, confused, short of breath, or have chest pain. If you feel well, call your PH team or pharmacist right away with both drug names, the strengths, and the times of your last doses. Lie down, avoid standing up quickly, don’t drive, and don’t take your next riociguat or tadalafil dose until a clinician tells you what to do.
Medication reconciliation: one list, one pharmacy, every visit
“Medication reconciliation” is the healthcare term for comparing every list of your medicines and making sure they match. Hospitals do it at admission and discharge. You can do a version of it yourself, and for someone with pulmonary hypertension it may be one of the most protective habits there is.
Keep one master list
Lists are what stop Cialis and riociguat from meeting. Make a single list that includes everything, not just what you think of as “real” medicines. For each item, write the name on the bottle (brand and generic, if you know both), why you take it, how often, who prescribed it and the date you started. Include:
- All PH medicines, including inhaled, injected or infused treatments
- Heart, blood pressure and water pills
- Erectile dysfunction and prostate medicines, even those you use only occasionally
- Over-the-counter products, vitamins and supplements
- Anything bought online or abroad
- Recreational substances, including poppers, which matter for both drugs
Keep it on paper in your wallet and in your phone. Update it the same day any change is made, including stop dates for medicines you’ve been taken off.
Use one pharmacy where you can
A pharmacist can only spot an interaction between prescriptions they can see. Many people fill PH medicines through a specialty or mail-order pharmacy. Filling riociguat there and Cialis at a local store splits your record in two. If you need more than one pharmacy, give each a copy of your full list and ask them to add your outside medicines to your profile. Ask specifically whether they will alert you to Cialis and riociguat or any other PDE5 inhibitor if they appear together.
Show the list at every visit
Hand your list to every clinician, every time, including the dentist, urgent care and telehealth visits. Don’t rely on shared electronic records; different health systems don’t always talk to each other, and PH centers are often in a different system from your local doctor. Say out loud: “I have pulmonary hypertension and I take riociguat.” For many people, that one sentence is what stops a Cialis and riociguat prescription from ever being written.
Check online purchases
Online ED services and websites selling tadalafil without a real prescriber review are a common route to a Cialis and riociguat mix-up. If you use a telehealth service, answer the medication questions in full, including riociguat by name. Never buy ED medicine from a site that doesn’t require a prescription. The FDA’s BeSafeRx program explains how to confirm that an online pharmacy is licensed. Tadalafil products from unverified sellers may also contain unknown amounts of drug or other ingredients, which makes the interaction even harder to predict.
Clear out old bottles
After any switch, ask your pharmacist how to dispose of medicines you’ve stopped. Cancel automatic refills for anything no longer prescribed. Leftover tadalafil from a past PAH regimen is a real hazard once riociguat begins.
Switching between tadalafil and riociguat
Switching between a PDE5 inhibitor and riociguat is a normal part of PAH care, and when it is planned by the PH team it is done safely. The key is a waiting period so that Cialis and riociguat, or any PDE5 inhibitor and riociguat, don’t overlap in the body. The Adempas label describes these gaps:
| Direction of switch | What the Adempas label says |
|---|---|
| From sildenafil to riociguat | Stop sildenafil at least 24 hours before starting riociguat |
| From tadalafil to riociguat | Stop tadalafil at least 48 hours before starting riociguat |
| From riociguat to a PDE5 inhibitor | Stop riociguat at least 24 hours before starting the PDE5 inhibitor |
The label also advises monitoring for signs and symptoms of low blood pressure when the new medicine starts. Notice that the tadalafil gap is longer than the sildenafil gap. That reflects how much more slowly tadalafil leaves the body.
This table is for understanding, not for planning a switch on your own. Your PH team will set your exact stop and start dates, decide on the starting dose of the new medicine and tell you what to watch for. Ask them to write the dates down, and share them with your pharmacist and anyone who helps you manage your medicines. If you’re unsure on switch day whether to take a pill, call the PH team before taking it.
A switch is also a good time to ask whether your ED plans fit the new regimen. A person moving from tadalafil to riociguat loses an ED-active medicine and gains one that rules out ED pills. That change is worth discussing openly before it happens.
Warning signs of low blood pressure
Riociguat lowers blood pressure even when taken alone, and the label notes that some people are at higher risk, including those who are dehydrated, already have low blood pressure, take blood pressure medicines, or have certain heart conditions. Taking Cialis and riociguat together, or adding any PDE5 inhibitor, raises that risk sharply. Learn the signs:
- Dizziness or light-headedness, especially when you stand up
- Feeling faint, or passing out
- Blurred or “greying out” vision
- Unusual tiredness or weakness
- Nausea
- Pale, cold or clammy skin
- A fast or pounding heartbeat
- New or worse shortness of breath
When to get help right away
Call 911 or your local emergency number for fainting, chest pain, severe shortness of breath, confusion, or signs of stroke such as face drooping, arm weakness or slurred speech. Tell responders you have pulmonary hypertension, and list your medicines, including riociguat and any tadalafil, sildenafil or other ED medicine, with the time of the last dose. Emergency teams need to know because some standard emergency treatments, including nitrates, are contraindicated with both drugs.
For milder symptoms, sit or lie down, rise slowly, drink water unless you’ve been told to limit fluids, avoid alcohol, and call your PH team the same day. Milder dizziness can also come from other blood pressure lowering medicines, such as alpha blockers for the prostate; our article on Cialis and tamsulosin covers that interaction.
Questions for each member of your care team
Different team members hold different pieces of the picture. Tailor your questions to who you’re talking to.
For your pulmonary hypertension specialist
- Given that Cialis and riociguat can’t be combined, what are my options for erectile dysfunction?
- If my regimen changes, what are my exact stop and start dates, and what should I watch for?
- Would a PDE5 inhibitor-based PAH regimen be appropriate for me, and how would that affect ED treatment?
- Can you send a note to my primary care doctor and urologist stating that PDE5 inhibitors are contraindicated with my treatment?
- What blood pressure reading or symptoms should prompt me to call you?
For your urologist or primary care doctor
- Have you seen my full medicine list, including my PH medicines from the specialty center?
- Are there ED treatments that don’t involve PDE5 inhibitors that would suit me?
- Will you check with my PH specialist before prescribing anything new for erections or the prostate?
- Is my erectile dysfunction worth evaluating for other causes, such as blood vessel health, hormones or medicine side effects?
- Is my current prostate or blood pressure medicine adding to my dizziness?
For your pharmacist
- Does my profile include every medicine I take, including those filled by my specialty pharmacy?
- Will your system flag Cialis and riociguat, or any PDE5 inhibitor with riociguat, if both are ever prescribed?
- Are any of my medicines the same drug under two different brand names?
- Which over-the-counter or online products should I check with you first?
- How do I safely get rid of medicines from my old regimen?
Putting it together
Cialis and riociguat should not be used together. Both increase cGMP, one by making more of it and the other by slowing its breakdown, and the combined effect can drop blood pressure dangerously low. The labels for both drugs say so plainly. For people with PAH or CTEPH, the bigger challenge is practical: care spread across several specialists, the same molecule sold under several names, and planned switches between drug classes. Back in Daniel’s story, the prescription would likely never have been written if he had handed over a complete medicine list or filled both prescriptions at the same pharmacy. Make that your habit. Keep one list, share it every time, use one pharmacy where you can, and ask your PH specialist first before starting any ED medicine. Questions about Cialis and riociguat are welcome at every one of those visits. If you use tadalafil for erectile dysfunction and want to understand the different ways it can be prescribed, our guide to Cialis daily vs. as-needed dosing may help, and more guides are available on the MedScott blog.
Sources
- ADEMPAS (riociguat) tablets prescribing information — DailyMed, U.S. National Library of Medicine
- CIALIS (tadalafil) tablets prescribing information — DailyMed, U.S. National Library of Medicine
- VERQUVO (vericiguat) tablets prescribing information — DailyMed, U.S. National Library of Medicine
- Adempas supplement approval letter (S-019), August 2026: riociguat REMS no longer required — U.S. Food and Drug Administration
- Tadalafil — MedlinePlus Drug Information
- About BeSafeRx — U.S. Food and Drug Administration